Mouse Monoclonal SLC40A1 antibody. Suitable for WB and reacts with Human samples. Cited in 19 publications. Immunogen corresponding to Recombinant Fragment Protein within Human SLC40A1 aa 100-350.
View Alternative Names
FPN, FPN1, IREG1, SLC11A3, MSTP079, SLC40A1, Ferroportin, Ferroportin-1, Iron-regulated transporter 1, Solute carrier family 40 member 1
- WB
Supplier Data
Western blot - Anti-SLC40A1 antibody [C2] (AB239583)
All lanes:
Western blot - Anti-SLC40A1 antibody [C2] (ab239583) at 5 µg/mL
All lanes:
Recombinant human SLC40A1 protein
Predicted band size: 63 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of this transporter is important for iron homeostasis in human body. SLC40A1 helps balance iron levels by moving iron across intestinal cells into the plasma. It does not function as part of a larger protein complex but its activity is controlled by hepcidin a hormone that degrades SLC40A1 and regulates iron flow into the circulation.
Pathways
SLC40A1 is essential in the iron homeostasis pathway and the hepcidin regulation pathway. These pathways ensure iron supply matches body demands. It is closely related to hepcidin due to their interactive roles in this regulatory system. Hepcidin binds to SLC40A1 leading to its internalization and degradation which decreases iron export.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
Journal of orthopaedic surgery and research 20:835 PubMed40999516
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1567942 PubMed40535769
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70609 PubMed40394754
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 32:2009-2021 PubMed40369167
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:1275-1293 PubMed39897035
2025
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e37477 PubMed39421383
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pharmaceutical analysis 14:86-99 PubMed38352945
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 39:101817 PubMed37939630
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 28: PubMed37375197
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 165:426-444 PubMed36802066
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com